Skip to main navigation
 

CytomX

 
  • About
    • Overview
    • Mission, Vision, Values
    • Executive Team
    • Board of Directors
    • Contact Us
  • Probody Therapeutics
    • Our Probody Approach
    • How Probody Therapeutics Work
    • A Versatile Platform
    • Scientific Publications & Presentations
  • Pipeline
    • Advancing a Pipeline
    • Lead Candidates
    • Clinical Trials
    • Access for HCPs/Patients
  • Partners
    • Opportunities
    • Current Partners
  • Investors & News
    • Corporate Profile
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Investor Resources
  • Culture & Careers
    • Overview
    • Xtraordinary Culture
    • Current Openings
    • Total Rewards Program
    • Corporate Amenities
Menu

Exciting things are happening here

SEC Filing Details

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 27, 2023
Document Date
Dec 31, 2022
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
CytomX Therapeutics, Inc.
Issuer
CytomX Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT
  • Corporate Profile
  • Press Releases
  • Events and Presentations
  • Scientific Publications
  • Corporate Governance
  • Stock Information
  • Financials & Filings
  • Analyst Coverage
  • Investor Resources
  • Investor Tools

  • Print Page
  • Email Page
  • RSS Feeds
  • Email Alerts
  • Contact IR

Contact Us

151 Oyster Point Blvd, Suite 400

South San Francisco, CA

94080-1913

IR@CytomX.com

Share

Linkedin Twitter © CYTOMX INC | CYTOMX, our corporate logo, IHZ, and PROBODY are trademarks of CytomX Therapeutics, Inc. All other brands and trademarks referenced herein are the property of their respective owners.
  • About
    • Overview
    • Mission, Vision, Values
    • Executive Team
    • Board of Directors
    • Contact Us
  • Probody Therapeutics
    • Our Probody Approach
    • How Probody Therapeutics Work
    • A Versatile Platform
    • Scientific Publications & Presentations
  • Pipeline
    • Advancing a Pipeline
    • Lead Candidates
    • Clinical Trials
    • Access for HCPs/Patients
  • Partners
    • Opportunities
    • Current Partners
  • Investors & News
    • Corporate Profile
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Investor Resources
  • Culture & Careers
    • Overview
    • Xtraordinary Culture
    • Current Openings
    • Total Rewards Program
    • Corporate Amenities
  • Home
    • Terms of Use
    • Privacy Policy